TABLE 1.
Demographic information per cohort and tracer.
| Demographic | |||||
|---|---|---|---|---|---|
| Cohort | AMYPAD DPMS | ADNI | |||
| Tracer | FMM | FBB | FBP | p‐value | Total |
| N | 207 | 123 | 203 | NA | 533 |
| Age | 70.4 ± 7.0 | 70.7 ± 7.5 | 72.1 ± 5.7 | 0.08 | 71.1 ± 6.7 |
| Sex (female%) | 99 (47.8%) | 39 (31.7%) | 83 (40.9%) | 0.02 | 221 (41.46%) |
| Clinical status | |||||
| CU+SCD | 79 (38.2%) | 31 (25.2%) | 60 (29.6%) | <0.001 | 170 (31.9%) |
| MCI | 90 (43.5%) | 44 (35.8%) | 104 (51.2%) | 238 (44.6%) | |
| Dementia | 38 (18.4%) | 48 (39%) | 39 (19.2%) | 125 (23.5%) | |
| Centiloid (Mean ±SD) | 36.9 ± 40.7 | 52.2 ± 45.1 | 46.84 ± 45.9 | 0.001 | 45.9 ± 46.0 |
Note: The p‐value represents the result of the between‐group comparison for demographic criteria.
Abbreviations: AD, Alzheimer's disease; ADNI, Alzheimer's Disease Neuroimaging Initiative; CU, cognitively unimpaired; FBB, 18F‐Florbetaben; FBP, 18F‐Florbetapir; FMM, 18F‐Flutemetamol; MCI, mild cognitive impairment; NA: Not applicable; SCD, subjective cognitive decline.
Bold values indicate p‐values < 0.05.